ESTRAGON PHARMACEUTICALS

In their own words

At Estragon we aspire to be an outstanding Global Ayurveda brand having specialization in formulation and development of Ayurvedic herbal medicine to counter health related issues either seasonal, hereditary or of modern lifestyle . All formulas are designed and screened by eminent and awarded expert in the form of Dr.Y.D. Sharma who happens to be one of the founder member of this company and who has contributed more than 40 years of services to Ayurveda as Professor, Clinician and Administrator. The project envisages setting up of a WHO-GMP certified unit for manufacturing of Herbal Pharmaceutical Oral Liquid (Syrup/Suspension) and Capsules. The installed capacity of the plant is Herbal Pharmaceutical Oral Liquid (Syrup) - 12,00,000 Litres per annum and Capsules – 10,24,000 Bottles per annum. The operating capacity is assumed at 30%, 35%, 40%, 50%, 60%, 70%,80% and 90% during the first, second, third, fourth, fifth, sixth, seventh, eighth year onwards. The cost of the project is estimated at Rs. 1,100.81 lakhs (INR 11cr) including investment in working capital of Rs. 500.00 lakhs (INR 5Cr for 3-4 months material, labour, salary, utility bills etc.). The net profitability (after tax) is assumed at 52% in first year with growth of 4-5% in net profitability every year. The site layout has been designed as per the requirements and guidelines given by National and International Health Authorities. The future plan for the plant is to proceed for WHO and other international certifications such as EU and USFDA, TGA, Health Canada, so that product manufactured can be exported to other countries also. The unit has leased factory land admeasuring 6,420 Sq. Mtrs situated at Harchandpur Village, Baghpat, Uttar Pradesh. The unit is in process of constructing factory building admeasuring 1,100 Sq. Mtrs with an estimated total cost of Rs. 281.90 lakhs to set up the unit for manufacturing of Herbal Pharmaceutical Oral Liquid and Capsules. The location is having good infrastructural facilities and well connected to the roads and transportation. The premises will also be suitable for expansion purpose and herbal medicine farming. Out of INR 11 Cr, 2 Cr has been floated by current Directors. ESTRAGON is open for INR 9 Cr investment by venture capitals for an equity in the company. Profit sharing with Investors will be shared with investment proportionality criteria. All investors participating through equity partnership will hold the seat in the board and will be informed on progress through General Meeting

Written by the company on its public Startup India profile. Not verified by us.